<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">445326344</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180317142722.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">170323e20110301xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1007/s10989-011-9244-1</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)springer-10.1007/s10989-011-9244-1</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
   <subfield code="a">Quantitative Structure-Activity Relationship Model for Prediction of Protein-Peptide Interaction Binding Affinities between Human Amphiphysin-1 SH3 Domains and Their Peptide Ligands</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="c">[Yuan Ding, Yong Lin, Mao Shu, Yuanqiang Wang, Li Wang, Xiaoming Cheng, Zhihua Lin]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">Protein-protein interaction plays a critical role in signal transduction and many other key biological processes. The present study evaluated four parameters selected from among 554 physiochemical variables of 20 natural amino acids listed in AAindex, namely, hydrophobicity, electronic properties, steric properties, and hydrogen-bond properties. Human amphiphysin-1 Src homology 3 (SH3) domain-binding decapeptides were the object of analysis. A quantitative structure-activity relationship model of the SH3 domain-binding peptides was constructed using multivariate linear regression. The results showed that the four parameters ably characterize the structure of SH3 domain-binding decapeptides, have definitive physicochemical properties and a low level of computational complexity, are accessible, and may be used in integrated prediction models for other protein-peptide interactions.</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">Springer Science+Business Media, LLC, 2011</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">SH3 domains</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Peptide ligand</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Quantitative structure-activity relationship, QSAR</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Multivariate linear regression analysis, MLR</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Ding</subfield>
   <subfield code="D">Yuan</subfield>
   <subfield code="u">School of Pharmacy and Bioengineering, Chongqing University of Technology, 400050, Chongqing, People's Republic of China</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Lin</subfield>
   <subfield code="D">Yong</subfield>
   <subfield code="u">School of Pharmacy and Bioengineering, Chongqing University of Technology, 400050, Chongqing, People's Republic of China</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Shu</subfield>
   <subfield code="D">Mao</subfield>
   <subfield code="u">School of Pharmacy and Bioengineering, Chongqing University of Technology, 400050, Chongqing, People's Republic of China</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Wang</subfield>
   <subfield code="D">Yuanqiang</subfield>
   <subfield code="u">School of Pharmacy and Bioengineering, Chongqing University of Technology, 400050, Chongqing, People's Republic of China</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Wang</subfield>
   <subfield code="D">Li</subfield>
   <subfield code="u">Institute of Immunology of PLA, Third Military Medical University, 400038, Chongqing, People's Republic of China</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Cheng</subfield>
   <subfield code="D">Xiaoming</subfield>
   <subfield code="u">Institute of Respiratory Diseases, Xinqiao Hospital, Third Military Medical University, 400037, Chongqing, People's Republic of China</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Lin</subfield>
   <subfield code="D">Zhihua</subfield>
   <subfield code="u">School of Pharmacy and Bioengineering, Chongqing University of Technology, 400050, Chongqing, People's Republic of China</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">International Journal of Peptide Research and Therapeutics</subfield>
   <subfield code="d">Springer Netherlands</subfield>
   <subfield code="g">17/1(2011-03-01), 75-79</subfield>
   <subfield code="x">1573-3149</subfield>
   <subfield code="q">17:1&lt;75</subfield>
   <subfield code="1">2011</subfield>
   <subfield code="2">17</subfield>
   <subfield code="o">10989</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1007/s10989-011-9244-1</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">research-article</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1007/s10989-011-9244-1</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Ding</subfield>
   <subfield code="D">Yuan</subfield>
   <subfield code="u">School of Pharmacy and Bioengineering, Chongqing University of Technology, 400050, Chongqing, People's Republic of China</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Lin</subfield>
   <subfield code="D">Yong</subfield>
   <subfield code="u">School of Pharmacy and Bioengineering, Chongqing University of Technology, 400050, Chongqing, People's Republic of China</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Shu</subfield>
   <subfield code="D">Mao</subfield>
   <subfield code="u">School of Pharmacy and Bioengineering, Chongqing University of Technology, 400050, Chongqing, People's Republic of China</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Wang</subfield>
   <subfield code="D">Yuanqiang</subfield>
   <subfield code="u">School of Pharmacy and Bioengineering, Chongqing University of Technology, 400050, Chongqing, People's Republic of China</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Wang</subfield>
   <subfield code="D">Li</subfield>
   <subfield code="u">Institute of Immunology of PLA, Third Military Medical University, 400038, Chongqing, People's Republic of China</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Cheng</subfield>
   <subfield code="D">Xiaoming</subfield>
   <subfield code="u">Institute of Respiratory Diseases, Xinqiao Hospital, Third Military Medical University, 400037, Chongqing, People's Republic of China</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Lin</subfield>
   <subfield code="D">Zhihua</subfield>
   <subfield code="u">School of Pharmacy and Bioengineering, Chongqing University of Technology, 400050, Chongqing, People's Republic of China</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">International Journal of Peptide Research and Therapeutics</subfield>
   <subfield code="d">Springer Netherlands</subfield>
   <subfield code="g">17/1(2011-03-01), 75-79</subfield>
   <subfield code="x">1573-3149</subfield>
   <subfield code="q">17:1&lt;75</subfield>
   <subfield code="1">2011</subfield>
   <subfield code="2">17</subfield>
   <subfield code="o">10989</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">Springer special CC-BY-NC licence</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-springer</subfield>
  </datafield>
 </record>
</collection>
